Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
1
20%
Ph phase_4
2
40%
Ph phase_1
2
40%

Phase Distribution

2

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 42 (40.0%)

Trials by Status

completed480%
terminated120%

Recent Activity

0 active trials
Showing 5 of 5
terminatedphase_4

Ziprasidone And Olanzapine's Outcomes In Mania

NCT00329108
completedphase_4

An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression

NCT00835107
completedphase_1

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions

NCT01581879
completedphase_1

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions

NCT01581866
completedphase_2

Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders

NCT00676429

Clinical Trials (5)

Showing 5 of 5 trials
NCT00329108Phase 4

Ziprasidone And Olanzapine's Outcomes In Mania

Terminated
NCT00835107Phase 4

An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression

Completed
NCT01581879Phase 1

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions

Completed
NCT01581866Phase 1

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions

Completed
NCT00676429Phase 2

Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5